M28 Capital Management LP purchased a new position in shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 439,300 shares of the biotechnology company’s stock, valued at approximately $1,441,000. Atara Biotherapeutics makes […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) has been given a consensus rating of “Hold” by the nine analysts that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The average […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) has earned a consensus recommendation of “Hold” from the nine research firms that are covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating on the company. The […]
Atara Biotherapeutics Announces First Quarter 2023 Financial Results and Operational Progress streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) has earned a consensus recommendation of “Hold” from the nine analysts that are presently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and three have issued a buy recommendation on the company. The […]